| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Nov 12, 2012 | Device startup aims to bring implantable solution to the problem of central sleep apnea | This novel therapy is meant to prove better clinical outcomes than the standard treatments, which include CPAP masks, drugs and other types of airflow devices.
Labosky said that data from a feasibility study showed that the remede device is... |
| Sep 12, 2012 | Fundraising: Startup developing nonsurgical treatment for urinary incontinence raises $3.9M | Solution/product: The Renessa System uses a probe guided through the urethra and radio frequency energy to treat female stress urinary incontinence in lieu of surgical treatments. The product has been cleared by the U.S. Food and Drug Admin... |
| Aug 6, 2012 | Respicardia Receives $6M Senior Credit Facility from Ares Capital Corporation | Respicardia, Inc., a near Minneapolis, Minnesota-based early stage company developing a medical device targeted to improve respiratory and cardiovascular health by treating central sleep apnea, has received a $6m senior secured credit facil... |
| Jan 10, 2012 | Mounty Airy’s DailyWorth raises $2 million | Welcome to the VC Roundup, where we’ll parse through venture capital news related to Philadelphia-based private equity firms and the companies they fund. Subscribe to the roundup as an email newsletter. If you have any VC-related news to pa... |
| Dec 9, 2011 | Another Mount Rushmore of med tech (MedCity readers’ version) | “How does Dean Kaman get on the Medical Device monument before Tom Fogarty?” asked one commenter.
“Agree,” wrote another. “Kamen is a very smart guy who gets a lot of press, but Med-Tech-wise is not even in the same league with Mann, Fogart... |
| Nov 9, 2011 | Inova Labs Secures $17.5M in Series B Funding | Inova Labs, an Austin, Texas-based medical device company focused on developing innovative products for the Chronic Obstructive Pulmonary Disease (COPD) market, has secured an up to $17.5m Series B round of equity financing.
The round was l... |
| Jun 24, 2011 | N.C. diagnostics firm LipoScience files for $86M IPO | LipoScience plans to use proceeds from its stock offering to expand its sales and marketing and fund continued R&D for new tests to supplement an already commercialized blood test to gauge the risk of cardiovascular disease. LipoScience... |
| May 19, 2009 | Satiety secures $7.5M bridge for tummy tuck shortcut | Satiety, maker of a minimally-invasive device that shrinks stomach capacity via the mouth, has landed a $7.5 million bridge loan from its existing investors — a group that includes Skyline Ventures, HLM Venture Partners, Pinnacle Ventures, ... |
| Apr 17, 2009 | iScience sees $20.5M for eye surgery instruments | iScience Interventional, maker of surgical tools for eye operations, has closed a prolonged sixth round of funding at $20.5 million after facing a bit more of a challenge due to the economic climate. The money will be used to commercialize ... |
| Feb 4, 2009 | SpinalMotion stacks up $500K for fake spinal discs | Artificial spinal disc producer SpinalMotion, just tacked $500,000 onto its $20 million third round of funding through a patent licensing agreement with an unnamed corporation. Based in Mountain View, Calif., the company makes both cervical... |
| Feb 4, 2009 | Allux Medical shuts down, turns to Sherwood | Silicon Valley shutdown/turnaround consultancy Sherwood Partners has been called in by ailing Allux Medical, a Menlo Park, Calif.-based developer of devices used to treat airway and skin inflammatory diseases. The company, which managed to ... |
| Dec 16, 2008 | IPO market freezes out two more health care startups | Poor market conditions have dashed the IPO hopes of two more health care companies — clinical data provider Epocrates and cardiovascular drug developer Aegerion Pharmaecuticals. This makes 38 companies across all sectors that have had to pu... |
| Nov 20, 2008 | Arete nabs $16.7M more to treat metabolic disorders | Biotech company Arete Therapeutics brought in $16.7 million in the final tranche of a first round of funding that now totals $51 million. The Hayward, Calif.-based company will use the money to push its lead treatment for metabolic syndrome... |
| Sep 2, 2008 | Spinal device developer Baxano raises $20M | Baxano, a startup in stealth mode that’s developing a spinal medical device, has raised $20 million in a second round of funding, according to VentureWire. The round was led by new backer Kearny Venture Partners, with participation from exi... |
| Aug 11, 2008 | Voyage Medical raises $22M for heart treatment | Voyage Medical, which is developing new treatment for a heart condition called atrial fibrillation, has raised $22 million in a second round of financing. New investor Three Arch Partners led the round, with participation from Kleiner Perki... |
| Jul 19, 2007 | Satiety pulls in $30M for obesity device | Satiety, a Palo Alto, Calif., device maker focused on obesity, raised $30 million in a fourth round of funding. Skyline Ventures led the round, joined by HLM Venture Partners, Pinnacle Ventures, Venrock, Three Arch Partners, Morgenthaler Ve... |
| May 23, 2007 | Arete raises $35M for cardiovascular treatments | Arete Therapeutics, a Hayward, Calif., developer of biotech cardiovascular treatments, raised a $35 million extension to its first round of funding. Founded in 2003, the company is working on “small molecule” drugs that target a metabolism-... |
| May 11, 2007 | NeuroVista raises $33.8M for epilepsy devices | (CORRECTED: See below.)
Seattle-based NeuroVista, a developer of devices for the treatment of epilepsy, raised $33.8 million in a second-round funding and left behind its former name, BioNeuronics.
The company, founded in 2002 by whiz kid D... |
| May 10, 2007 | Pegasus Bio gets $20M for surgical-repair bioimplants | Pegasus Biologics, an Irvine, Calif., maker of flexible-but-strong tissue substitutes designed to speed muscle-tendon repair or wound healing, raised $20 million in a third round of funding.
Despite the word “biologics” in its name — a term... |
| Nov 5, 2004 | Three Arch boots wine-lover | Three Arch Partners, the Silicon Valley healthcare VC firm, has ousted co-founder Thomas Fogarty, the wine-lover who owns the Thomas Fogarty vineyard in Woodside.
Scoop comes from The Venture Capital Analyst, which unfortunately requires a ... |
| Fundraising: Startup developing nonsurgical treatment for urinary incontinence raises $3.9M | Company name: Novasys Medical Inc.
Industry: medical devices.
Location: Newark, California.
Solution/product: The Renessa System uses a probe guided through the urethra and radio frequency energy to treat female stress urinary incontinence ... |
| Device startup aims to bring implantable solution to the problem of central sleep apnea | For the past six years, Minnesota device startup Respicardia has been trying to commercialize a product that President and CEO Bonnie Labosky believes has no rival worldwide.
It is an implantable device, the size of a pacemaker, that can be... |
| Another Mount Rushmore of med tech (MedCity readers’ version) | It turns out the name (or face) of Dean Kamen may not be etched in stone.
We got great feedback on Arundhati Parmar’s list of people she’d place on the Mount Rushmore of med tech. Her choices: Medtronic’s Earl Bakken, the original medical d... |
| N.C. diagnostics firm LipoScience files for $86M IPO | Diagnostics company LipoScience aims to become North Carolina’s next public company.
Raleigh, North Carolina-based LipoScience has filed with securities regulators plans to raise up to $86.2 million in an initial public stock offering. It’s... |